The November-December issue of Retinal Physician contained an article by Dr. Emily Chew, Deputy Director of The Division of Ophthalmology and CLinical Research at the National Eye Institute.
[caption id="attachment_502" alig
Many people suffering from obesity turn to gastric bypass surgery as a weight loss solution. The procedure is not without its risks and resulting problems. Vitamin deficiencies are a side effect of gastric bypass surgery as well as other abdominal surgeries. A deficiency in Vitamin A may result in n
Many people suffering from depression turn to the herbal supplement, St. John's Wort, as a natural remedy. A new study, however, found a relationship between use of the herb and the development of cataracts.
Obesity is a major risk factor in both the onset and progression of several sight-threatening conditions. Despite this, a majority of the public is unaware of the link between obesity and vision loss. A recent study conducted by the Eyecare Trust found that only 8% of those surveyed connected obesit
Iritis is an inflammation of the iris. Iritis can be caused by an underlying condition such as juvenile rheumatoid arthritis. Lupus, Sarcoid, Shingles or inflammatory bowel disease or trauma to the eye, among others. In approximately half of cases, iritis occurs spontaneously without a known cause.
Technological advances in ophthalmology allow eye doctors to more accurately diagnose and treat diseases of the eye. Instead of relying upon a vision screening to catch underlying problems with the eyes, an OCT scan provides eye doctors with a 3D look of the retina.
A national study finds that cataract surgery proves to be beneficial to age-related macular degeneration (AMD) patients. The American Academy of Opthalmology details this report in their November issue of
Phytosterols, long known for their cholesterol-lowering action, are emerging as cancer-fighting powerhouses. Phytosterols, the structural components in the cell membranes of plants, have long been known to reduce serum total and LDL cholesterol levels. Now, new research indicates that they may help to prevent cancer as well.
It was just a few months ago on the VisiVite Blog that we published studies regarding stem cell research for treatment of eye disease which shortly followed the new federal laws that were enacted.
But in a scientfic stem-cell breakthrough today out of the University of Wisconsin (Madison), resear
Insulin, a hormone manufactured by the islet cells in the Pancreas, is critical to good health. Insulin doesn?t dissolve glucose; rather, it moves glucose (simple sugar) out of the bloodstream and into the cells in muscle and the liver, where it is converted into glycogen, an energy storage molecule
If you haven't joined Facebook yet, you're missing out on my Ask The Eye Doctor group. (not to mention all the people from high school who you've long forgotten!)
Let's face it - we all have questions when we go to th
Are you concerned about the state of musical education in our country?
If so, I must share with all of you a speech given last week by Wynton Marsalis.
Marsalis, who has won a Pulitzer Prize in Music a
The Geron Corporation, based in Menlo Park, California, reported in a news release that the United States Food and Drug Administration (FD) cleared the company's Investigational New Drug application for the clinical trial of GRNOPC1 for the specific use in patients with subacute complete thoracic spinal cord injuries.
As this season's football teams celebrated their respective division championships with champagne, with corks flying around the room painting each others' faces with the pressurized spray, I was motivated to warn my readers about avoiding a potentially devastating eye injury.
Just three months ag
Poor Genentech. The company is making the news frequently these days. And it?s not about new drug discoveries or other scientific breakthroughs that is earning the company such press, but rumors of the compan
Welcome to the VisiVite Blog, featuring subjects about eye health and alternative treatments for macular degeneration and dry eye syndrome, in particular.? My intention for the blog is to discuss the the latest eye health news, eye care research, and alternative eye treatment solutions. I also hope
It seems highly unlikely that one company would produce two drugs, at different prices, that treat the same ailment, and be in the middle of a medical industry dispute, but that's exactly the case of Genentech Inc.
Lucentis, a federally approved drug for the most severe form of macular degenerati